Literature DB >> 10516211

Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat.

T D Le Cras1, D H Kim, S Gebb, N E Markham, J M Shannon, R M Tuder, S H Abman.   

Abstract

The Fawn-Hooded rat (FHR) strain develops accelerated and severe pulmonary hypertension when exposed to slight decreases in alveolar PO(2). We recently observed that adult FHR lungs showed a striking pattern of disrupted alveolarization and hypothesized that abnormalities in lung growth in the perinatal period predisposes the FHR to the subsequent development of pulmonary hypertension. We found a reduction in lung weight in the fetus and 1-day- and 1-wk-old FHR compared with a normal rat strain (Sprague-Dawley). Alveolarization was reduced in infant and adult FHR lungs. In situ hybridization showed similar patterns of expression of two epithelial markers, surfactant protein C and 10-kDa Clara cell secretory protein, suggesting that the FHR lung is not characterized by global delays in epithelial maturation. Barium-gelatin angiograms demonstrated reduced background arterial filling and density in adult FHR lungs. Perinatal treatment of FHR with supplemental oxygen increased alveolarization and reduced the subsequent development of right ventricular hypertrophy in adult FHR. We conclude that the FHR strain is characterized by lung hypoplasia with reduced alveolarization and increased risk for developing pulmonary hypertension. We speculate that altered oxygen sensing may cause impaired lung alveolar and vascular growth in the FHR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516211     DOI: 10.1152/ajplung.1999.277.4.L709

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

1.  Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Authors:  Robert F Wideman; Krishna R Hamal
Journal:  J Pharmacol Toxicol Methods       Date:  2011-01-26       Impact factor: 1.950

2.  Noninvasive ventilation for the management of pulmonary hypertension associated with congenital heart disease in children.

Authors:  H J Bunn; P Roberts; A H Thomson
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

3.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

Authors:  Richard D Bland; Kurt H Albertine; David P Carlton; Amy J MacRitchie
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

4.  Effect of PKC isozyme inhibition on forskolin-induced activation of BKCa channels in rat pulmonary arterial smooth muscle.

Authors:  Shu Zhu; Richard E White; Scott A Barman
Journal:  Lung       Date:  2006 Mar-Apr       Impact factor: 2.584

5.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.

Authors:  Y Kasahara; R M Tuder; L Taraseviciene-Stewart; T D Le Cras; S Abman; P K Hirth; J Waltenberger; N F Voelkel
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 6.  Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension.

Authors:  Sébastien Bonnet; Steeve Provencher; Christophe Guignabert; Frédéric Perros; Olivier Boucherat; Ralph Theo Schermuly; Paul M Hassoun; Marlene Rabinovitch; Mark R Nicolls; Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

7.  Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitro.

Authors:  Jason Gien; Gregory J Seedorf; Vivek Balasubramaniam; Nancy Tseng; Neil Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

Review 8.  Reactive oxygen species in pulmonary vascular remodeling.

Authors:  Saurabh Aggarwal; Christine M Gross; Shruti Sharma; Jeffrey R Fineman; Stephen M Black
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

Review 9.  Antenatal hypoxia and pulmonary vascular function and remodeling.

Authors:  Demosthenes G Papamatheakis; Arlin B Blood; Joon H Kim; Sean M Wilson
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

10.  Blunted hypoxic pulmonary vasoconstriction in experimental neonatal chronic lung disease.

Authors:  Gloria Juliana Rey-Parra; Stephen L Archer; Richard D Bland; Kurt H Albertine; David P Carlton; Soo-Chul Cho; Beth Kirby; Al Haromy; Farah Eaton; Xichen Wu; Bernard Thébaud
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.